AstraZeneca has built resilient supply chains in the U.S. and China for years, doesn't expect much tariff impact, CEO says

featured-image

AstraZeneca CEO Pascal Soriot discusses earnings, the potential trade tariff impact on the business and the outlook for the firm's key markets.

Monday - Friday, 08:00 - 11:00 CET | 14:00 - 17:00 HK/SG.